Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRRE: Attenuated E. coli Challenge Model Pilot
NCT03596827Completed
- Sponsor
- NIZO Food Research
- Start
- Sep 2018
- Primary completion
- Nov 2018
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Randomised, double-blind trial of escherichia coli strain E1392/75-2A in enterotoxigenic Escherichia coli infection (5 arms), sponsored by NIZO Food Research. Primary endpoint: Change in specific antibody titer at Day 49. Started Sep 2018; status: completed.
02
Drugs
escherichia coli strain E1392/75-2A
03
Conditions
enterotoxigenic Escherichia coli infection
Beyond the preview
Go deeper on NCT03596827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03596827.